Chapter 11. Management and Pharmaceutical Treatment of Central and Spinal Spasticity

  1. Livia Candelise1,
  2. Richard Hughes2,
  3. Alessandro Liberati3,
  4. Bernard M.J. Uitdehaag4 and
  5. Charles Warlow5
  1. David T. Shakespeare

Published Online: 12 NOV 2007

DOI: 10.1002/9780470988350.ch11

Evidence-based Neurology: Management of Neurological Disorders

Evidence-based Neurology: Management of Neurological Disorders

How to Cite

Shakespeare, D. T. (2007) Management and Pharmaceutical Treatment of Central and Spinal Spasticity, in Evidence-based Neurology: Management of Neurological Disorders (eds L. Candelise, R. Hughes, A. Liberati, B. M.J. Uitdehaag and C. Warlow), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470988350.ch11

Editor Information

  1. 1

    Cochrane Neurological Network, Ospedale Magglore Policlinico, University of Milan, Italy

  2. 2

    King's College London School of Medicine at Guy's, King's College and St Thomas' Hospitals, London, UK

  3. 3

    Università di Modena e Reggio Emillia, Modena, Italy

  4. 4

    VU University Medical Center, Amsterdam, The Netherlands

  5. 5

    University of Edinburgh, Western General Hospital, Edinburgh, UK

Publication History

  1. Published Online: 12 NOV 2007
  2. Published Print: 1 JAN 2007

ISBN Information

Print ISBN: 9780727918116

Online ISBN: 9780470988350

SEARCH

Keywords:

  • spasticity;
  • oral anti-spasticity drugs;
  • intrathecal (IT) drug infusion;
  • butulinum toxin BTX;
  • physiotherapy

Summary

This chapter contains sections titled:

  • Background

  • Framing clinical questions

  • Critical review of evidence

  • Conclusion